Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
US Army

Generated: December 12, 2017

DrugPatentWatch Database Preview

Oxaprozin - Generic Drug Details

« Back to Dashboard

What are the generic sources for oxaprozin and what is the scope of oxaprozin patent protection?

is the generic ingredient in three branded drugs marketed by Gd Searle, Actavis Elizabeth, Amneal Pharms Co, Apotex Inc, Dr Reddys Labs Ltd, Ivax Sub Teva Pharms, Mylan, Mylan Pharms Inc, Sandoz, Sun Pharm Inds Inc, Teva, and Watson Labs, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for oxaprozin. Twenty-two suppliers are listed for this compound.

Pharmacology for oxaprozin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva PharmsOXAPROZINoxaprozinTABLET;ORAL075846-001May 13, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Actavis ElizabethOXAPROZINoxaprozinTABLET;ORAL075843-001Oct 3, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozOXAPROZINoxaprozinTABLET;ORAL075842-001Apr 12, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Amneal Pharms CoOXAPROZINoxaprozinTABLET;ORAL208633-001May 4, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaOXAPROZINoxaprozinTABLET;ORAL075849-001Jul 3, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm Inds IncOXAPROZINoxaprozinTABLET;ORAL075844-001Jan 3, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Gd SearleDAYPROoxaprozinTABLET;ORAL018841-004Oct 29, 1992ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsOXAPROZINoxaprozinTABLET;ORAL075848-001Feb 9, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Apotex IncOXAPROZINoxaprozinTABLET;ORAL075987-001Sep 2, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan Pharms IncOXAPROZINoxaprozinTABLET;ORAL075847-001Feb 28, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
US Army
Farmers Insurance
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: